Assets dip, affiliations shift: Stalin, Udhayanidhi among Tamil Nadu leaders reporting lower wealthM. K. Stalin, Udhayanidhi Stalin and other Dravida Munnetra Kazhagam leaders have reported a decline in declared assets over five years, la...
JNJ stock price today: Why Johnson & Johnson shares dropped despite strong 2026 forecast? Here's what investors are watchingJNJ stock price today: Johnson & Johnson stock saw a dip even as the company projected robust 2026 sales and profit figures. Legal issues, ...
J&J settlement plan over baby powder lawsuit deniedRed River Talc LLC, a J&J subsidiary, was seeking confirmation of a proposed prepackaged Chapter 11 bankruptcy plan that would have been on...
J&J Q2 Results: Pharma major beats Wall Street estimates on strong drug salesJohnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer ...
J&J Q4 Results: Profit edges past Street view after deals delay Stelara competitionJohnson & Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psor...
J&J issues cautious 2023 forecast, shares fallThe company was "responsibly optimistic" about 2023, Chief Financial Officer Joseph Wolk said on a conference call, pointing to fierce comp...
US CDC recommends Pfizer, Moderna COVID-19 shots over J&J'sUntil now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all of...
Indemnity issues may hold up availability of J&J single dose vaccineWhile the drug regulator has given a nod to Biological E to manufacture the vaccine at its plant in Telangana, its launch looks unlikely ti...
Johnson and Johnson Covid jab gets emergency use approvalWith this, Johnson and Johnson became third foreign-made vaccine to get nod after Sputnik V, Moderna; permission is only for imports of the...
Germany sets no limits on use of J&J COVID-19 shotGermany's vaccine committee, known as STIKO, has limited the use of AstraZeneca's COVID-19 shot to those aged 60 and above due to the risk ...
Johnson & Johnson Q1 profit, sales jump, beats Wall Street forecastThe one weak spot was a small drop in consumer health sales, which saw a surge in 2020's first quarter, when nervous consumers stocked up o...
Johnson & Johnson 'under stress' to meet EU second-quarter vaccine supply goal: SourceAny delay would be a further blow to EU's vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slo...
Arvind Kejriwal had urged Railways Minister Suresh Prabhu to look into JJ dwellers issue in December 1 letterArvind Kejriwal had written to Prabhu urging him to look into the issue of rehabilitation of JJ dwellers staying along the rail track on "p...
China deploys supersonic trainer aircraft for pilot trainingThe aircraft has been developed and manufactured by Guizhou Aviation Industry Group, a subsidiary of Aviation Industry Corp of China.
Johnson & Johnson to buy back shares up to $10 billionThe company said on Tuesday it had about 2.77 billion shares of common stock outstanding as of Sept. 27.
- J&J posts higher Q1 profit, mainly on 1-time gain
The world's biggest maker of health care products may be on the mend, reporting a slight increase in profit on Tuesday, after the recession...
- J&J's Q3 net up to $3 bn on drug sales
Johnson & Jaohnson, the world’s biggest maker of medical devices, said third-quarter earnings rose 8.7% on increased sales of drugs, consum...